← SynDRA
NEPICASTAT
SynDRA canonical compound SYN0022861 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DBH |
|---|
| Mechanism of action | dopamine beta hydroxylase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- dopamine beta hydroxylase inhibitor
- DBH INHIBITOR
Cross-references
Synonyms
- SYN-117
- SYN117
- Nepicastat oral
- nepicastatum
- VPG12K4540
- CHEBI:139334
- RefChem:165475
- DTXCID6092231
- Nepicastat [INN]
- UNII-VPG12K4540
- Nepicastat [WHO-DD]
- SCHEMBL662220
- GTPL6630
- orb1689394
- SCHEMBL29386883
- YZZVIKDAOTXDEB-JTQLQIEISA-N
- GLXC-06923
- AKOS016001464
- CS-0515
- NCGC00346651-01
- NCGC00346651-04
- NCGC00346651-09
- AC-27759
- FN103230
- HY-13289
- NS00069610
- SYN117;RS-25560-197
- T60633
- BRD-K09126848-003-01-9
- BRD-K09126848-003-02-7
- RS-25560-197
- نپیکاستات
- S2695
- orb1300622
- SCHEMBL1230129
- Nepicastat (hydrochloride)
- nepicastat hydrochloride anhydrous
- 3WK068D17I
Look up NEPICASTAT in the interactive SynDRA portal →